BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9341774)

  • 1. Antigen-specific CD8+ T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection.
    Cose SC; Jones CM; Wallace ME; Heath WR; Carbone FR
    Eur J Immunol; 1997 Sep; 27(9):2310-6. PubMed ID: 9341774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.
    Jones CM; Cose SC; McNally JM; Jennings SR; Heath WR; Carbone FR
    J Gen Virol; 2000 Feb; 81(Pt 2):407-14. PubMed ID: 10644839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro.
    McNally JM; Andersen HA; Chervenak R; Jennings SR
    Cell Immunol; 1999 May; 194(1):103-11. PubMed ID: 10357886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
    Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
    Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope.
    Bonneau RH; Fu TM; Tevethia SS
    Virology; 1993 Dec; 197(2):782-7. PubMed ID: 7504370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of herpes simplex virus-specific helper T lymphocyte precursors in the lymph node cells of infected mice.
    Prymowicz D; Moore RN; Rouse BT
    J Immunol; 1985 Apr; 134(4):2683-8. PubMed ID: 2579150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection.
    Pantaleo G; Soudeyns H; Demarest JF; Vaccarezza M; Graziosi C; Paolucci S; Daucher MB; Cohen OJ; Denis F; Biddison WE; Sekaly RP; Fauci AS
    Eur J Immunol; 1997 Dec; 27(12):3166-73. PubMed ID: 9464802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
    Yasukawa M; Inatsuki A; Kobayashi Y
    J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node.
    Takeuchi A; Itoh Y; Takumi A; Ishihara C; Arase N; Yokosuka T; Koseki H; Yamasaki S; Takai Y; Miyoshi J; Ogasawara K; Saito T
    J Immunol; 2009 Oct; 183(7):4220-8. PubMed ID: 19752223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
    J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo.
    Fernandez MA; Evans IA; Hassan EH; Carbone FR; Jones CA
    Eur J Immunol; 2008 Jan; 38(1):102-13. PubMed ID: 18081035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.